Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
05/11/2023 | Avantor, Inc. | AVTR | Grant | Common Stock | 9.8k | $0.00 | $0 | | 05/11/2023 |
05/12/2022 | Avantor, Inc. | AVTR | Grant | Common Stock | 6.7k | $0.00 | $0 | | 05/12/2022 |
04/01/2022 | Avantor, Inc. | AVTR | Grant | Common Stock | 1.2k | $0.00 | $0 | | 04/01/2022 |
03/31/2021 | Bellerophon Therapeutics, Inc. | BLPH | Grant | Common Stock | 15.3k | $0.00 | $0 | | 03/31/2021 |
02/25/2021 | Avantor, Inc. | AVTR | Grant | Common Stock | 7.2k | $0.00 | $0 | | 02/25/2021 |
02/21/2020 | Avantor, Inc. | AVTR | Grant | Common Stock | 11.3k | $0.00 | $0 | | 02/21/2020 |
01/23/2020 | Bellerophon Therapeutics, Inc. | BLPH | Grant | Common Stock | 350k | $0.00 | $0 | | 01/23/2020 |
05/21/2019 | Avantor, Inc. | AVTR | Grant | Common Stock | 14.3k | $0.00 | $0 | | 05/21/2019 |
05/21/2019 | Avantor, Inc. | AVTR | Exercise | Existing Junior Convertible Preferred | 1000 | $0.00 | $0 | | 05/21/2019 |
05/21/2019 | Bellerophon Therapeutics, Inc. | BLPH | Purchase | Common Stock | 20k | $0.61 | $12.2k | | 05/21/2019 |
01/25/2019 | Bellerophon Therapeutics, Inc. | BLPH | Purchase | Common Stock | 714.3k | $0.70 | $500k | | 01/25/2019 |
01/23/2019 | Bellerophon Therapeutics, Inc. | BLPH | Grant | Common Stock | 227.3k | $0.00 | $0 | | 01/23/2019 |
04/02/2018 | Bellerophon Therapeutics, Inc. | BLPH | Grant | Common Stock | 99k | $0.00 | $0 | | 04/02/2018 |
09/29/2017 | Bellerophon Therapeutics, Inc. | BLPH | Purchase | Common Stock | 249k | $0.00 | $0 | | 09/29/2017 |
09/29/2017 | Bellerophon Therapeutics, Inc. | BLPH | Purchase | Common Stock Warrants (right to buy) | 249k | $1.24 | $309.2k | | 09/29/2017 |
09/22/2017 | Bellerophon Therapeutics, Inc. | BLPH | Grant | Stock Option (right to buy) | 10k | $1.12 | $11.2k | | 09/22/2017 |
06/28/2017 | Bellerophon Therapeutics, Inc. | BLPH | Grant | Common Stock | 58k | $0.00 | $0 | | 06/28/2017 |
06/20/2017 | Kite Pharma, Inc. | KITE | Grant | Common Stock | 2.4k | $0.00 | $0 | | 06/20/2017 |
06/20/2017 | Kite Pharma, Inc. | KITE | Grant | Director Stock Option (Right to Buy) | 8.8k | $91.21 | $803.6k | | 06/20/2017 |
12/07/2016 | Bellerophon Therapeutics, Inc. | BLPH | Grant | Stock Option (right to buy) | 588.4k | $0.49 | $288.3k | | 12/07/2016 |
11/29/2016 | Bellerophon Therapeutics, Inc. | BLPH | Purchase | Common Stock | 285.7k | $0.00 | $0 | | 11/29/2016 |
11/29/2016 | Bellerophon Therapeutics, Inc. | BLPH | Purchase | Common Stock Warrants (right to buy) | 285.7k | $0.80 | $228.6k | | 11/29/2016 |
06/01/2016 | Kite Pharma, Inc. | KITE | Grant | Common Stock | 2k | $0.00 | $0 | | 06/01/2016 |
06/01/2016 | Kite Pharma, Inc. | KITE | Grant | Director Stock Option (Right to Buy) | 7k | $50.87 | $356.1k | | 06/01/2016 |
05/17/2016 | Bellerophon Therapeutics, Inc. | BLPH | Purchase | Common Stock | 5k | $1.37 | $6.8k | | 05/17/2016 |
01/25/2016 | Bellerophon Therapeutics, Inc. | BLPH | Grant | Common Stock | 166k | $0.00 | $0 | | 01/25/2016 |
12/16/2015 | Bellerophon Therapeutics, Inc. | BLPH | Purchase | Common Stock | 12.8k | $2.76 | $35.3k | | 12/15/2015 |
12/15/2015 | Bellerophon Therapeutics, Inc. | BLPH | Purchase | Common Stock | 7.5k | $2.72 | $20.4k | | 12/15/2015 |
08/19/2015 | Bellerophon Therapeutics, Inc. | BLPH | Purchase | Common Stock | 5k | $5.48 | $27.4k | | 08/19/2015 |
06/09/2015 | Kite Pharma, Inc. | KITE | Grant | Stock Option (Right to Buy) | 10k | $59.23 | $592.3k | | 06/09/2015 |
05/20/2015 | Bellerophon Therapeutics, Inc. | BLPH | Purchase | Common Stock | 5.6k | $8.69 | $48.3k | | 05/20/2015 |
03/12/2015 | Bellerophon Therapeutics, Inc. | BLPH | Grant | Stock Option (right to buy) | 16k | $10.22 | $163.5k | | 03/12/2015 |
03/12/2015 | Bellerophon Therapeutics, Inc. | BLPH | Grant | Stock Option (right to buy) | 60k | $10.22 | $613.2k | | 03/12/2015 |
02/19/2015 | Bellerophon Therapeutics, Inc. | BLPH | Purchase | Common Stock | 20.8k | $12.00 | $249.6k | | 02/19/2015 |
06/25/2014 | Kite Pharma, Inc. | KITE | Other (acquisition) | Common Stock | 66k | $15.30 | $1M | | 06/25/2014 |